Unlike macrophages, monocytes and platelets that mediate hepatotoxicity, CRS and thrombocytopenia, respectively, cDC1 activation by CD40 agonist do not contribute to any of these dose-limiting toxicities. This evidence concerns the gene CD40 and Thrombocytopenia.